Who are Intravenous Lidocaine's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lidocaine (drug), lidocaine infusion, Bupivacaine Liposomes(BL), Dexamethasone+ Bupivacaine, Lidocaine gel 2%, Ropivacaine 0.2% for LFCB.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intravenous-lidocaine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Intravenous Lidocaine — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravenous Lidocaine (Intravenous Lidocaine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic; antiarrhythmic agent. Area: Anesthesia; Cardiology; Pain management.

marketed Local anesthetic; antiarrhythmic agent Voltage-gated sodium channels Anesthesia; Cardiology; Pain management Small molecule Live · refreshed every 30 min

Target snapshot

Intravenous Lidocaine (Intravenous Lidocaine) — Khon Kaen University. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Intravenous Lidocaine TARGET	Intravenous Lidocaine	Khon Kaen University	marketed	Local anesthetic; antiarrhythmic agent	Voltage-gated sodium channels
Lidocaine (drug)	Lidocaine (drug)	Daniel A Tonetti, MD	marketed	Local anesthetic	Voltage-gated sodium channels
lidocaine infusion	lidocaine infusion	Medical University of Warsaw	marketed	Local anesthetic / Sodium channel blocker	Voltage-gated sodium channels
Bupivacaine Liposomes(BL)	Bupivacaine Liposomes(BL)	Huazhong University of Science and Technology	marketed	Local anesthetic (liposomal formulation)	Voltage-gated sodium channels
Dexamethasone+ Bupivacaine	Dexamethasone+ Bupivacaine	Ain Shams University	marketed	Corticosteroid + Local anesthetic combination	Glucocorticoid receptor (dexamethasone); Voltage-gated sodium channels (bupivacaine)
Lidocaine gel 2%	Lidocaine gel 2%	Atlantic Health System	marketed	Local anesthetic	Voltage-gated sodium channels
Ropivacaine 0.2% for LFCB	Ropivacaine 0.2% for LFCB	Poznan University of Medical Sciences	marketed	Local anesthetic (amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic; antiarrhythmic agent class)

Khon Kaen University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intravenous Lidocaine — Competitive Intelligence Brief. https://druglandscape.com/ci/intravenous-lidocaine. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab